Description: Fiona is an LNG IUS, currently marketed in India. It consists of a T- frame with a drug reservoir containing 52mg levonorgestrel, and thereby releases 20μg per day in the uterine cavity for up to 5 years. Fiona is provided with a preloaded applicator designed for a simpler and painless insertion.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Intrauterine

Duration Type: Long-acting

Duration: 5 years

  • Single insertion

Dose: 20μg/day

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Meril Life Science Private Ltd

Project Phase: Limited Market Availability

Development Stage: Marketed

Active Development: Yes

Status Details:
  • Fiona is currently marketed in India only. The manufacturer hopes to expand to other markets.
  • Clinical trials are underway to support applications for other markets.

Additional Information


Vertical Tabs